by S. Allegrezza and P. May

Within the last 15 years DNA sequencing and, in particular, Next Generation Sequencing (NGS) or Massive Parallel Sequencing (MPS) have revolutionised human genetics research. It is now possible to sequence a complete human genome inexpensively and more efficiently.

(+ info)

by A. Sengupta and E. Letellier

Notwithstanding the recent run of breakthroughs in the realms of microbiomes and cancers–two complex systems on their own–much remains unknown at their interface: The Cancer Microbiome.

(+ info)

by L. Ratti, C. Vögele and A. Kornadt

Prior to the onset of the Covid-19 pandemic, the debate on the future of work revolved around two concurrent narratives: the omnipresent automation of working environments and the emergence of new forms of work, facilitated by technology.

(+ info)

by J. Mendes and A-L. Högenauer

The role of European Central Bank (ECB) in monetary policy and in European Economic and Monetary Union (EMU) law and politics has changed fundamentally in the past decade.

(+ info)

by J. Lagerwall and H. Voos

With TRANSCEND we will create the foundation for an infrastructure that currently does not exist, yet is dearly needed to keep up with emerging trends in robotics and automation.

(+ info)

by A. Skupin, J. Klein and M. Esposito

Epilepsy is the fourth most common neurological disorder characterised by recurrent seizures and a rather heterogeneous clinical appearance with 30% of patients not responding to available drug treatments.

(+ info)